
Commercializing a Dedicated
Breast CT Platform for the Earlier Detection, Diagnosis and Treatment of
Breast Cancers
“Izotropic has conducted significant technical, clinical and market-positioning efforts that provide a high level of confidence that the final product will meet patient, physician and marketplace requirements.”
-StarFish Medical Founder and CEO Scott Phillips
Latest News